ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Governors Hear Pitch For State Cancer Control Increased Effort

August 3, 1979

Four Win 1988 General Motors Cancer Prizes

June 17, 1988

MD Anderson Expands Reach Into Florida, Ohio

September 26, 2014

Cancergrams Cost $840 Year For All

December 2, 1977

NCI Seeks 150 Advocates For Advice On Plans, Policies.

March 2, 2001